CUHK Innovation

CUHK Innovation Limited is the wholly-owned investment and commercialization arm of The Chinese University of Hong Kong (CUHK). Established in late 2022, the company serves as a strategic bridge between academic research and industrial application, focusing on nurturing and investing in CUHK-affiliated startups and spin-offs. It manages an early-stage venture fund that targets high-growth sectors, particularly biotechnology, healthcare, artificial intelligence, and robotics. By providing capital, strategic guidance, and access to the university's extensive research infrastructure, CUHK Innovation Limited aims to accelerate the translation of scientific breakthroughs into market-ready solutions. Its portfolio includes innovative ventures in areas such as microbiome-based therapeutics, advanced diagnostics, and surgical robotics.